| The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds SV Tavtigian, J Simard, J Rommens, F Couch, D Shattuck-Eidens, ... Nature genetics 12 (3), 333-337, 1996 | 1147 | 1996 |
| Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology MB Daly, T Pal, MP Berry, SS Buys, P Dickson, SM Domchek, ... Journal of the National Comprehensive Cancer Network 19 (1), 77-102, 2021 | 792 | 2021 |
| BRCA1 regulates human mammary stem/progenitor cell fate S Liu, C Ginestier, E Charafe-Jauffret, H Foco, CG Kleer, SD Merajver, ... Proceedings of the National Academy of Sciences 105 (5), 1680-1685, 2008 | 597 | 2008 |
| International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment S Dawood, SD Merajver, P Viens, PB Vermeulen, SM Swain, TA Buchholz, ... Annals of oncology 22 (3), 515-523, 2011 | 569 | 2011 |
| Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis Q Pan, CG Kleer, KL Van Golen, J Irani, KM Bottema, C Bias, ... Cancer research 62 (17), 4854-4859, 2002 | 524 | 2002 |
| NCCN guidelines insights: genetic/familial high-risk assessment: breast and ovarian, version 2.2017 MB Daly, R Pilarski, M Berry, SS Buys, M Farmer, S Friedman, JE Garber, ... Journal of the National Comprehensive Cancer Network 15 (1), 9-20, 2017 | 515 | 2017 |
| Somatic mutations in the BRCA1 gene in sporadic ovarian tumours SD Merajver, TM Pham, RF Caduff, M Chen, EL Poy, KA Cooney, ... Nature genetics 9 (4), 439-443, 1995 | 511 | 1995 |
| Assessment and counseling for women with a family history of breast cancer: a guide for clinicians KF Hoskins, JE Stopfer, KA Calzone, SD Merajver, TR Rebbeck, ... Jama 273 (7), 577-585, 1995 | 505 | 1995 |
| Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers SA Narod, MP Dubé, J Klijn, J Lubinski, HT Lynch, P Ghadirian, ... Journal of the National Cancer Institute 94 (23), 1773-1779, 2002 | 498 | 2002 |
| BRCA2 germline mutations in male breast cancer cases and breast cancer families FJ Couch, LM Farid, ML DeShano, SV Tavtigian, K Calzone, L Campeau, ... Nature genetics 13 (1), 123-125, 1996 | 446 | 1996 |
| RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype KL van Golen, ZF Wu, XT Qiao, LW Bao, SD Merajver Cancer research 60 (20), 5832-5838, 2000 | 443 | 2000 |
| Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study GJ Brewer, RD Dick, DK Grover, V LeClaire, M Tseng, M Wicha, K Pienta, ... Clinical Cancer Research 6 (1), 1-10, 2000 | 435 | 2000 |
| Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy in BRCA1/2-Associated Stage I/II Breast Cancer LJ Pierce, AM Levin, TR Rebbeck, MA Ben-David, E Friedman, LJ Solin, ... Journal of Clinical Oncology 24 (16), 2437-2443, 2006 | 427 | 2006 |
| NCCN guidelines insights: genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 1.2020: featured updates to the NCCN guidelines MB Daly, R Pilarski, MB Yurgelun, MP Berry, SS Buys, P Dickson, ... Journal of the National Comprehensive Cancer Network 18 (4), 380-391, 2020 | 407 | 2020 |
| Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor–negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23 B Fisher, S Anderson, E Tan-Chiu, N Wolmark, DL Wickerham, ER Fisher, ... Journal of clinical oncology 19 (4), 931-942, 2001 | 363 | 2001 |
| A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast … KL van Golen, S Davies, Z Fen Wu, YF Wang, CD Bucana, H Root, ... Clinical Cancer Research 5 (9), 2511-2519, 1999 | 347 | 1999 |
| BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants F Elstrodt, A Hollestelle, JHA Nagel, M Gorin, M Wasielewski, ... Cancer research 66 (1), 41-45, 2006 | 339 | 2006 |
| Targeting breast cancer stem cell state equilibrium through modulation of redox signaling M Luo, L Shang, MD Brooks, E Jiagge, Y Zhu, JM Buschhaus, S Conley, ... Cell metabolism 28 (1), 69-86. e6, 2018 | 338 | 2018 |
| Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability CG Kleer, KL van Golen, Y Zhang, ZF Wu, MA Rubin, SD Merajver The American journal of pathology 160 (2), 579-584, 2002 | 306 | 2002 |
| Molecular biology of breast cancer metastasis Inflammatory breast cancer: clinical syndrome and molecular determinants CG Kleer, KL Van Golen, SD Merajver Breast Cancer Research 2, 1-7, 2000 | 302 | 2000 |
Max WichaZweryfikowany adres z umich.edu
